Study That Tests AD109 in Patients Taking GLP-1 Drugs

NCT06400615 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Apnimed